Traditional financial analysis does not easily apply to the science and business of the Biotechnology firms. Biotech’s business is operating […]
Author: Djenan Ganic
CDISC EU Interchange 2019
Looking forward to CDISC EU Interchange 2019 – where we will present our experiences and challenges on defining clinical protocols […]
intilaris presents at 2018 PhUSE EU Connect in Frankfurt
intilaris is proud to be among the presenters at the upcoming 2018 PhUSE EU Connect in Frankfurt. The conference is […]
Why we fail at the BEGINNING of the End-to-End (E2E) clinical data standardization
Clinical trial protocols are largely written as documents aimed at the communication of the trial to the local Ethics Committees, […]
TransCelerate Common Protocol Template: Considerations for Sponsor Adoption
Assumption on my side is that if you are reading this article, then you probably are familiar with the TransCelerate […]
